Remove Adverse Reactions Remove Hospitals Remove Labelling
article thumbnail

STAT+: Experts critique flawed system for monitoring drugs’ side effects in wake of asthma drug report

STAT

and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address. “The question is, how safe do you want to be?” Experts say that the Singulair incident highlights a flawed system, both in the U.S. “Are we at the right balance?

article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

Adverse reactions to the vaccine. After collecting the information, they print a plastic barcode label that can send the recipient’s vaccination records to the cloud with a simple scan. In a rollout of this magnitude, point of care facilities need to collect comprehensive vaccination data on: Individual patient records.

Vaccines 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Penicillin allergy delabelling: A multidisciplinary approach for improved patient care

Hospital Pharmacy Europe

In developed countries, between five and 15% patients carry a penicillin allergy label , and patients receive a penicillin allergy label by their third birthday in approximately 75% of cases. However, a large body of evidence suggests upwards of 90% of patients with a penicillin allergy label are not truly allergic.

article thumbnail

Mounjaro interactions to avoid

The Checkup by Singlecare

Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor Mounjaro (tirzepatide) is gaining popularity as a treatment for Type 2 diabetes mellitus and off-label for weight management. The ones that it does have are important, though.

article thumbnail

NICE recommends epcoritamab for diffuse large B-cell lymphoma after two or more lines of treatment

Hospital Pharmacy Europe

The new recommendation means adults with DLBCL whose cancer has returned or has not responded to at least two previous treatments, and who have previously had polatuzumab vedotin or it is contraindicated or not tolerated, will have access to epcoritamab subcutaneous bispecific treatment option administered in a hospital setting.

article thumbnail

FDA Approvals: September 2022 Recap

Digital Pharmacist

Common adverse reactions include conjunctival/ocular hyperemia, photophobia, blurred vision, dry eye, pain, headache, irritation, and visual impairment. . Rolvedon was supported by data from two Phase 3, randomized, open-label, non-inferiority clinical trials, ADVANCE, and RECOVER, which evaluated safety and efficacy.

FDA 75
article thumbnail

Meclizine interactions to avoid

The Checkup by Singlecare

While some interactions may be mild, others may lead to serious side effects or adverse reactions. Here are some common steps to take: Check the label : Always read the drug information in the product package for potential warnings, and follow the instructions on your prescription label for the appropriate dosage.